Lymphoma Clinical Trials in Maastricht, Limburg
4 recruitingMaastricht, Limburg, Netherlands
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Relapsed/Refractory Non-Hodgkin Lymphoma
Bristol-Myers Squibb308 enrolled35 locationsNCT06090539
Recruiting
Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Genmab496 enrolled75 locationsNCT05283720
Recruiting
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Lung CancerLymphoma
Academisch Ziekenhuis Maastricht30 enrolled1 locationNCT05654675
Recruiting
Phase 4
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Lung CancerCarcinoma, Non-Small Cell LungDrug Monitoring+2 more
University Medical Center Groningen196 enrolled8 locationsNCT05525338